Status | Study |
Completed |
Study Name: AIDA 2000 Guidelines Condition: Acute Promyelocytic Leukemia Date: 2010-02-05 Interventions: Drug: all-trans retinoic acid (ATRA) |
Terminated |
Study Name: Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2009-09-25 Interventions: Drug: Tamibarotene Self-admini |
Recruiting |
Study Name: Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2008-05-07 Interventions: Drug: NRX 195183 Soft Gelatin Capsule Daily oral NRX 195183 administration for 90 days to assess CR rate |
Withdrawn |
Study Name: New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2008-04-28 Interventions: Drug: NRX 195183 (retinoid analogue) |
Completed |
Study Name: A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL) Condition: Leukemia, Promyelocytic, Acute Date: 2007-12-27 Interventions: Drug: Arac Ommit ARAC in the chemotherapy Other Name |
Completed |
Study Name: APL93: Timing of CxT and Role of Maintenance Condition: Leukemia, Promyelocytic, Acute Date: 2007-12-27 Interventions: Drug: ATRA early introduction |
Completed |
Study Name: Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL Condition: Acute Promyelocytic Leukemia Date: 2007-08-21 Interventions: Drug: Tamibarotene For induction therapy, tamibarotene will be self-administered via tablets on an outpa |
Recruiting |
Study Name: Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2007-08-16 Interventions: Drug: Single agent arsenic trioxide duration of maintenance therapy, 6 months versus 12 months |
Completed |
Study Name: Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) Condition: Acute Promyelocytic Leukemia Date: 2007-07-19 Interventions: Drug: Arsenic Trioxide |
Completed |
Study Name: Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) Condition: Acute Promyelocytic Leukemia Date: 2007-04-25 Interventions: Drug: AIDA |